Valuation : Provexis plc

Market Cap 25.22M 34.19M 29.46M 27.63M 47.51M 3.27B 47.66M 328M 128M 1.65B 128M 126M 5.47B P/E 2024
-20.9x
P/E 2025 -22.6x
Enterprise Value 24.51M 33.23M 28.64M 26.85M 46.17M 3.18B 46.32M 319M 124M 1.6B 125M 122M 5.32B EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 day+2.44%
1 week-6.67%
Current month-8.30%
1 month-7.89%
6 months-19.23%
Current year+16.67%
1 week 0.95
Extreme 0.95
1.25
1 month 0.95
Extreme 0.95
1.25
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 1999-12-31
Director TitleAgeSince
Director/Board Member - 2010-11-10
Chairman 79 2005-05-31
Director/Board Member 52 2019-04-11
Date Insider Type Main position Quantity % Market Cap.
1/7/25 Free

Chief Executive Officer

30,000,000 1.2788%
1/24/23 Free

Chief Executive Officer

17,000,000 0.7665%
1/24/23 Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
+2.44%-6.67%+42.86%+61.04% 33.4M
+0.67%-2.44%+9.00%+66.40% 12.38B
-5.43%-9.39%-16.82%+316.90% 9.19B
+0.10%+1.23%-19.74%-48.91% 2.45B
+0.30%+1.98%-16.49%-4.23% 1.54B
-0.33%-0.31%+22.12%+73.06% 1.36B
+0.65%-1.74%+27.10%-18.17% 1.3B
+4.19%+4.91%-73.96%-74.05% 1.24B
+0.75%+6.56%-41.67% - 1.12B
+7.05%+0.46%-61.82%-70.03% 967M
Average +1.04%+0.68%-12.94%+33.56% 3.16B
Weighted average by Cap. -0.87%+1.27%-7.87%+115.75%

Financials

2024 2025
Net sales 802K 1.09M 937K 879K 1.51M 104M 1.52M 10.42M 4.07M 52.46M 4.08M 3.99M 174M 1.29M 1.75M 1.51M 1.42M 2.43M 167M 2.44M 16.8M 6.55M 84.53M 6.58M 6.44M 280M
Net income -586K -795K -685K -642K -1.1M -75.97M -1.11M -7.62M -2.97M -38.35M -2.98M -2.92M -127M -453K -614K -529K -496K -853K -58.67M -856K -5.88M -2.3M -29.61M -2.3M -2.25M -98.2M
Net Debt -189K -257K -221K -207K -357K -24.54M -358K -2.46M -960K -12.39M -964K -943K -41.07M -708K -960K -827K -776K -1.33M -91.76M -1.34M -9.2M -3.59M -46.32M -3.6M -3.53M -154M
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
26-08-28 GBX 1.050 +2.44% 84,031
26-08-27 GBX 1.025 +0.49% 3,545,867
26-08-26 GBX 1.020 -6.42% 948,187
26-08-25 GBX 1.090 -3.11% 843,967
26-08-24 GBX 1.125 0.00% 86,363